BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15352990)

  • 21. Assessment of Platelia Aspergillus enzyme immunoassay for the diagnosis of invasive aspergillosis.
    Lai CC; Hsu HL; Lee LN; Hsueh PR
    J Microbiol Immunol Infect; 2007 Apr; 40(2):148-53. PubMed ID: 17446963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
    Pazos C; Pontón J; Del Palacio A
    J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Early diagnosis of invasive aspergillosis in neutropenic patients with bi-weekly serial screening of circulating galactomannan by Platelia Aspergillus].
    Pazos C; del Palacio A
    Rev Iberoam Micol; 2003 Sep; 20(3):99-102. PubMed ID: 15456365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combination of real-time polymerase chain reaction assay and serum galactomannan in the diagnosis of invasive aspergillosis in patients with hematological malignancies and recipients of hematopoietic stem cell transplantation].
    Sun YQ; Ji Y; Xu LP; Liu DH; Liu KY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):375-8. PubMed ID: 20367932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of sequential Aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation.
    Busca A; Locatelli F; Barbui A; Limerutti G; Serra R; Libertucci D; Falda M
    Transplant Proc; 2006 Jun; 38(5):1610-3. PubMed ID: 16797366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of the galactomannan assay for the diagnosis of invasive aspergillosis in patients].
    Wen YT; Zhao BL; Lü PH; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Apr; 31(4):287-90. PubMed ID: 18846967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients.
    Husain S; Paterson DL; Studer SM; Crespo M; Pilewski J; Durkin M; Wheat JL; Johnson B; McLaughlin L; Bentsen C; McCurry KR; Singh N
    Transplantation; 2007 May; 83(10):1330-6. PubMed ID: 17519782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem?
    Orlopp K; von Lilienfeld-Toal M; Marklein G; Reiffert SM; Welter A; Hahn-Ast C; Purr I; Gorschlüter M; Molitor E; Glasmacher A
    J Antimicrob Chemother; 2008 Nov; 62(5):1109-12. PubMed ID: 18647743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
    Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
    J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of clinical characteristics on the performance of galactomannan and PCR for the diagnosis of invasive aspergillosis in febrile neutropenic patients.
    Oz Y; Aslan M; Aksit F; Metintas S; Gunduz E
    Mycoses; 2016 Feb; 59(2):86-92. PubMed ID: 26627843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis.
    Desai R; Ross LA; Hoffman JA
    Pediatr Infect Dis J; 2009 Apr; 28(4):283-6. PubMed ID: 19238113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis.
    Hidalgo A; Parody R; Martino R; Sánchez F; Franquet T; Giménez A; Blancas C
    Eur J Radiol; 2009 Jul; 71(1):55-60. PubMed ID: 18468830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.
    Maertens J; Verhaegen J; Lagrou K; Van Eldere J; Boogaerts M
    Blood; 2001 Mar; 97(6):1604-10. PubMed ID: 11238098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum galactomannan levels in the diagnosis of invasive aspergillosis.
    Okuturlar Y; Ozkalemkas F; Ener B; Serin SO; Kazak E; Ozcelik T; Ozkocaman V; Ozkan HA; Akalin H; Gunaldi M; Ali R
    Korean J Intern Med; 2015 Nov; 30(6):899-905. PubMed ID: 26552466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children.
    Dinand V; Anjan M; Oberoi JK; Khanna S; Yadav SP; Wattal C; Sachdeva A
    J Microbiol Immunol Infect; 2016 Feb; 49(1):66-73. PubMed ID: 24582464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variables affecting the performance of galactomannan assay in high-risk patients at a tertiary care centre in India.
    Khanna S; Oberoi JK; Datta S; Aggarwal S; Wattal C
    Indian J Med Microbiol; 2013; 31(1):34-9. PubMed ID: 23508427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody specific to thioredoxin reductase as a new biomarker for serodiagnosis of invasive aspergillosis in non-neutropenic patients.
    Shi LN; Li FQ; Lu JF; Kong XX; Wang SQ; Huang M; Shao HF; Shao SH
    Clin Chim Acta; 2012 May; 413(9-10):938-43. PubMed ID: 22366166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the lightcycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with onco-haematological diseases.
    Cesaro S; Stenghele C; Calore E; Franchin E; Cerbaro I; Cusinato R; Tridello G; Manganelli R; Carli M; Palù G
    Mycoses; 2008 Nov; 51(6):497-504. PubMed ID: 18331444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients.
    Fortún J; Martín-Dávila P; Alvarez ME; Norman F; Sánchez-Sousa A; Gajate L; Bárcena R; Nuño SJ; Moreno S
    Transplantation; 2009 Jan; 87(2):256-60. PubMed ID: 19155981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.